How To Streamline Your Global Pharmacovigilance Management Process While Reducing Costs

Pharmacovigilance has become extremely important as regulatory groups become more concerned about the serious side effects of a product found after it has launched to the patient population. There are new requirements for companies to have a Risk Management Plan in place to be launched for any new product, and as regulations increase, more resources are required to support pharmacovigilance activities. Pharmaceutical companies, and soon medical device companies, will be challenged with figuring out how to support and streamline the management of pharmacovigilance. This white paper discusses the benefits of moving from tactical to strategic outsourcing on pharmacovigilance, and presents key ways that TransPerfect Life Sciences can help in this endeavor during the development and launch of new products.